What is Canadas Vaccine Safety Surveillance Plan for the H1N1 Flu Vaccine?
All vaccines authorized for use in Canada have been carefully tested for safety. The H1N1 flu vaccine has been authorized for use based on preliminary clinical trial data, and will continue to be monitored and tested as it is administered across the country. Immunization is one of the most effective ways to prevent the spread of infectious diseases. The benefit of immunization – the prevention of serious illness and death – far outweighs any risk associated with being immunized.